Author:
Newman Edward J.,Grosset Donald G.,Kennedy Peter G. E.
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine,Clinical Neurology
Reference31 articles.
1. Delay J, Pichot P, Lemperiere T, et al. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol (Paris). 1960;118(1):145–52.
2. Caroff SN, Mann SC, Campbell EC, et al. Neuroleptic malignant syndrome. In: Frucht SJ, Fahn S, editors. Movement disorder emergencies diagnosis and treatment. New York: Humana Press; 2005. p. 41–52.
3. Nisijima K, Ishiguro T. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiatr Res. 1995;29:233–44. doi: 10.1016/0022-3956(95)00007-R .
4. Kipps CM, Fung VS, Grattan-Smith P, et al. Movement disorder emergencies. Mov Disord. 2005;20:322–34. doi: 10.1002/mds.20325 .
5. Berardi D, Amore M, Keck PE Jr, et al. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry. 1998;44:748–54. doi: 10.1016/S0006-3223(97)00530-1 .
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献